Beijing, China

Dajun Deng


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2024

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Dajun Deng: Innovator in Cancer Research

Introduction

Dajun Deng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research, particularly in the development of methods for detecting genetic deletions and predicting cancer outcomes. With a total of 4 patents, his work has the potential to impact cancer diagnostics and treatment.

Latest Patents

Dajun Deng's latest patents include a method for quantitatively detecting the deletion of the human CDKN2A gene copy. This invention provides a set of primer pairs and probes with specific oligonucleotide sequences, enabling the detection of a common deleted region of the CDKN2A gene. The method offers higher sensitivity compared to conventional detection methods, making it a valuable tool for cancer diagnostics. Another notable patent involves methods and nucleotide fragments for predicting the occurrence and metastasis of cancers, as well as patients' postoperative survival. This invention utilizes in vitro measurements of methylation or demethylation of GFRa1 CpG islands to estimate tumorigenesis risk and life expectancy.

Career Highlights

Dajun Deng is affiliated with the Beijing Institute for Cancer Research, where he conducts his innovative research. His work focuses on developing advanced techniques for cancer detection and prognosis, contributing to the ongoing fight against cancer.

Collaborations

Dajun has collaborated with notable colleagues, including Jing Zhou and Zhaojun Liu, to further enhance the impact of his research in the field of cancer.

Conclusion

Dajun Deng's contributions to cancer research through his innovative patents demonstrate his commitment to improving cancer diagnostics and patient outcomes. His work continues to pave the way for advancements in the understanding and treatment of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…